Back to Search
Start Over
Survival and outcomes of patients with unoperated single ventricle.
- Source :
-
Heart (British Cardiac Society) [Heart] 2016 Feb; Vol. 102 (3), pp. 216-22. Date of Electronic Publication: 2015 Dec 23. - Publication Year :
- 2016
-
Abstract
- Objective: Patients with unoperated single ventricle (SV) rarely survive into adulthood with good functional status and may develop Eisenmenger's syndrome (ES). We report outcomes of a 30-year cohort of such patients.<br />Methods: Adult patients with unoperated SV were identified by searching the Mayo Clinic medical record from 1984 to 2014. Clinical data were collected and compared between patients with pulmonary stenosis (PS) and ES.<br />Results: 24 patients were identified (median peak-age 56 (31-77) years (11 ES, 13 PS); 22 had left ventricular morphology. 50-year transplant-free survival was 65% (95% CI 43 to 81). Median age at death was 55 years (31-77 years); 15 deaths (62%) occurred before oral pulmonary vasodilators were commercially available. Two-thirds of the cohort demonstrated preserved New York Heart Association functional class and median EF was 60% (49% to 62%). The majority of patients to survive into the fifth decade exhibited anatomy of double-inlet LV (DILV) with PS.<br />Conclusion: Selected patients with unoperated SV with PS and ES can survive with good functional class up to the eighth decade with good medical management. DILV/PS appears to be the ideal phenotype for advanced survival. Our outcomes may be considered when such patients with SV having 'balanced' physiology are evaluated for Fontan palliation. However, additional prospective study will be necessary to verify this assertion.<br /> (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/)
- Subjects :
- Adult
Aged
Cohort Studies
Eisenmenger Complex mortality
Eisenmenger Complex pathology
Endothelin Receptor Antagonists therapeutic use
Female
Heart Defects, Congenital mortality
Heart Defects, Congenital pathology
Heart Defects, Congenital therapy
Humans
Male
Middle Aged
Phosphodiesterase 5 Inhibitors therapeutic use
Prostaglandins I therapeutic use
Pulmonary Valve Stenosis mortality
Pulmonary Valve Stenosis pathology
Retrospective Studies
Stroke Volume
Survival Rate
Cardiac Pacing, Artificial methods
Eisenmenger Complex therapy
Pulmonary Valve Stenosis therapy
Vasodilator Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1468-201X
- Volume :
- 102
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Heart (British Cardiac Society)
- Publication Type :
- Academic Journal
- Accession number :
- 26701967
- Full Text :
- https://doi.org/10.1136/heartjnl-2015-308440